| 摘要 |
PURPOSE: A pharmaceutical composition containing 5-(6-quinoxalinylmethylene)-2,4-thiazolidinedione(Cas No: 648450-29-7) is provided to prevent entrance of inflammatory cells into bronchial alveolar. CONSTITUTION: A pharmaceutical composition for treating and preventing bronchial asthma contains 5-(6-quinosalinylmethylene)-2,4-thiazolidinedione(Cas No: 648450-29-7). The composition is manufactured in the form of powder, granule, tablet, capsule, suspension, syrup, oral formulation of aerosol, suppository, or injection. The composition prevents or treats bronchial asthma by administering into mammal except for human. The composition is administered by airway injection.
|
